FACTBOX-Vaccines delivered under COVAX sharing scheme for poorer countries

by Reuters
Friday, 26 November 2021 13:46 GMT

(Updates Bolivia, Egypt, Indonesia, Ivory Coast, Kyrgyzstan, Madagascar, Mauritania, Pakistan, Togo, Tunisia) Nov 26 (Reuters) - The COVAX facility, backed by the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI), has delivered more than 537 million COVID-19 vaccine doses to 144 countries, GAVI data shows. In September, the organizations running the facility had to cut their 2021 delivery target by nearly 30% to 1.425 billion doses. The following tables list countries that have received vaccines under the scheme, sorted alphabetically: AFRICA & MIDDLE EAST COUNTRY LATEST DELIVERY DATE VACCINE TYPE POPULATION TOTAL DELIVERY DELIVERED Algeria 1.3 million October 21 Sinovac 44 million 2.4 million Angola 1.2 million November 17 AstraZeneca/Oxford 33 million 6.8 million Benin 336,000 November 4 J&J 12 million 1.1 million Botswana 300,000 October 1 AstraZeneca/Oxford 2.5 million 560,460 Burkina Faso 168,000 November 12 J&J 21 million 585,400 Cameroon 336,000 November 5 J&J 27 million 1.0 million Cape Verde 100,000 October 3 Moderna 556,000 124,000 Central 168,300 November 19 J&J 4.8 million 806,700 African Republic Chad 117,000 October 5 Pfizer/BioNTech 16 million 217,620 Comoros 12,000 April 12 AstraZeneca/Oxford 870,000 12,000 Islands Congo 168,000 November 15 J&J 5.5 million 470,400 Democratic 349,830 October 21 Pfizer/BioNTech 90 million 2.6 million Republic of Congo Djibouti 151,200 July 17 J&J 988,000 175,200 Egypt 2.1 million November 24 AstraZeneca/Oxford 102 million 14.9 million Eswatini 100,620 October 6 Pfizer/BioNTech 1.1 million 429,420 Ethiopia 655,200 September 23 J&J 115 million 5.3 million Gabon 101,790 November 1 Pfizer/BioNTech 2.2 million 370,410 Gambia 38,400 August 22 AstraZeneca/Oxford 2.4 million 376,800 Ghana 1.7 million November 22 N/A 31 million 6.7 million Guinea 168,000 November 14 J&J 13 million 1.7 million Guinea-Bissau 28,800 August 18 AstraZeneca/Oxford 2.0 million 360,000 Iran 1.4 million October 18 AstraZeneca/Oxford 84 million 3.9 million Iraq 500,000 August 14 Pfizer/BioNTech 40 million 836,000 Ivory Coast 506,200 November 24 J&J 26 million 6.6 million Jordan 146,400 June 3 AstraZeneca/Oxford 10 million 436,800 Kenya 376,800 November 16 AstraZeneca/Oxford 54 million 7.3 million Lebanon 33,600 March 24 AstraZeneca/Oxford 6.8 million 33,600 Lesotho 169,070 November 19 J&J 2.1 million 644,090 Liberia 168,000 October 24 J&J 5.1 million 662,400 Libya 230,490 November 21 Pfizer/BioNTech 6.9 million 721,890 Madagascar 398,970 November 25 Pfizer/BioNTech 28 million 1.3 million Malawi 360,000 October 23 AstraZeneca/Oxford 19 million 1.8 million Mali 835,200 October 5 Sinovac 20 million 1.5 million Mauritania 144,000 November 24 J&J 4.6 million 1.1 million Mauritius 107,640 November 15 Pfizer/BioNTech 1.3 million 183,690 Morocco 850,000 October 30 Pfizer/BioNTech 37 million 1.2 million Mozambique 840,000 November 22 J&J 31 million 3.3 million Namibia 124,000 October 22 Pfizer/BioNTech 2.5 million 291,200 Niger 100,800 September 2 AstraZeneca/Oxford 24 million 758,200 Nigeria 3.6 million October 16 Pfizer/BioNTech 206 million 12.0 million Palestinian 500,000 August 24 Moderna 4.7 million 664,400 Territories Rwanda 12,000 November 19 AstraZeneca/Oxford 13 million 1.9 million Sao Tome and 24,000 March 3 AstraZeneca/Oxford 219,000 24,000 Principe Senegal 265,590 November 15 Pfizer/BioNTech 17 million 2.9 million Seychelles 35,100 September 8 Pfizer/BioNTech 98,460 35,100 Sierra Leone 168,000 November 23 J&J 8.0 million 785,310 Somalia 336,500 November 7 J&J 16 million 1.2 million South Africa 5.6 million July 31 Pfizer/BioNTech 59 million 5.6 million South Sudan 60,000 November 16 AstraZeneca/Oxford 11 million 404,450 Sudan 499,590 October 7 Pfizer/BioNTech 44 million 2.1 million Syria 144,000 November 16 AstraZeneca/Oxford 17 million 1.7 million Tanzania 500,000 November 22 Pfizer/BioNTech 60 million 3.0 million Togo 633,600 November 25 J&J 8.3 million 3.0 million Tunisia 336,000 November 24 J&J 12 million 3.2 million Uganda 1.9 million November 13 Moderna 46 million 9.3 million Yemen 356,800 September 23 AstraZeneca/Oxford 30 million 868,000 Zambia 580,320 November 21 Pfizer/BioNTech 18 million 2.2 million Zimbabwe 943,200 October 1 Sinopharm 15 million 943,200 EUROPE COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL DELIVERY DATE DELIVERED Albania 40,800 June 2 AstraZeneca/Oxford 2.8 million 120,000 Armenia 187,200 September 5 AstraZeneca/Oxford 3.0 million 261,200 Azerbaijan 84,000 April 4 AstraZeneca/Oxford 10 million 84,000 Bosnia 32,760 May 10 Pfizer/BioNTech 3.3 million 82,560 Georgia 43,200 March 13 AstraZeneca/Oxford 3.7 million 43,200 Kosovo 503,100 September 6 Pfizer/BioNTech 1.8 million 701,220 Moldova 301,000 August 1 J&J 2.6 million 644,000 Montenegro 24,000 March 28 AstraZeneca/Oxford 622,000 24,000 North 38,400 May 14 AstraZeneca/Oxford 2.1 million 62,400 Macedonia Serbia 115,200 August 25 AstraZeneca/Oxford 6.9 million 292,800 Ukraine 2.9 million November 7 Moderna 44 million 7.4 million ASIA & PACIFIC COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL DELIVERY DATE DELIVERED Afghanistan 144,000 August 8 AstraZeneca/Oxford 39 million 4.2 million Bangladesh 1.8 million November 23 N/A 165 million 21.4 million Brunei 24,000 April 2 AstraZeneca/Oxford 437,000 24,000 Cambodia 324,000 November 15 AstraZeneca/Oxford 17 million 1.8 million East Timor 100,620 October 16 Pfizer/BioNTech 1.3 million 393,420 Fiji 50,400 November 18 Moderna 896,000 302,480 Indonesia 3.5 million November 23 Pfizer/BioNTech 274 million 30.8 million Kiribati 56,000 August 21 AstraZeneca/Oxford 119,000 104,000 Kyrgyzstan 115,200 November 25 Moderna 6.6 million 601,440 Laos 523,200 October 31 AstraZeneca/Oxford 7.3 million 2.3 million Malaysia 559,200 September 17 AstraZeneca/Oxford 32 million 1.4 million Maldives 112,000 August 23 AstraZeneca/Oxford 541,000 252,700 Mongolia 899,730 October 6 Pfizer/BioNTech 3.3 million 1.3 million Nauru 7,200 April 2 AstraZeneca/Oxford 10,830 7,200 Nepal 368,000 November 17 AstraZeneca/Oxford 29 million 5.4 million Pakistan 1.5 million November 13 Moderna 221 million 19.7 million Papua New 302,400 August 6 J&J 8.9 million 580,400 Guinea Philippines 793,900 November 9 AstraZeneca/Oxford 110 million 28.8 million Samoa 112,000 August 23 AstraZeneca/Oxford 198,410 136,000 Solomon 100,620 November 16 Pfizer/BioNTech 687,000 209,420 Islands Sri Lanka 800,000 October 1 Pfizer/BioNTech 22 million 4.0 million Tajikistan 198,900 November 19 Pfizer/BioNTech 9.5 million 2.5 million Tonga 36,800 August 25 AstraZeneca/Oxford 106,000 60,800 Tuvalu 4,800 April 8 AstraZeneca/Oxford 11,800 4,800 Uzbekistan 660,000 November 15 AstraZeneca/Oxford 34 million 8.8 million Vanuatu 24,000 May 19 AstraZeneca/Oxford 307,000 24,000 Vietnam 1.0 million November 18 Moderna 97 million 28.0 million AMERICAS COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL DELIVERY DATE DELIVERED Antigua and 19,200 November 22 N/A 98,000 60,000 Barbuda Argentina 960,400 October 12 AstraZeneca/Oxford 45 million 3.9 million Bahamas 57,330 October 18 Pfizer/BioNTech 393,000 124,530 Barbados 33,600 August 24 AstraZeneca/Oxford 287,000 100,800 Belize 58,500 October 26 Pfizer/BioNTech 398,000 159,300 Bermuda 9,600 April 6 AstraZeneca/Oxford 64,000 9,600 Bolivia 90,090 November 23 Pfizer/BioNTech 12 million 3.5 million Brazil 2.0 million September 20 Sinovac 213 million 11.9 million Chile 331,000 May 20 AstraZeneca/Oxford 19 million 489,400 Colombia 2.3 million October 25 Sinovac 51 million 11 million Costa Rica 86,400 September 5 AstraZeneca/Oxford 5.1 million 398,550 Dominica 11,700 September 21 Pfizer/BioNTech 72,000 40,500 Dominican 184,800 August 27 AstraZeneca/Oxford 11 million 463,200 Republic Ecuador 101,760 August 16 AstraZeneca/Oxford 18 million 857,760 El Salvador 188,370 August 27 Pfizer/BioNTech 6.5 million 3.6 million Grenada 21,600 May 26 AstraZeneca/Oxford 113,000 45,600 Guatemala 1.0 million November 18 Pfizer/BioNTech 17 million 3.3 million Guyana 100,620 October 8 Pfizer/BioNTech 787,000 220,620 Haiti 100,000 November 4 Moderna 11 million 600,000 Honduras 250,040 October 28 Moderna 9.9 million 4.8 million Jamaica 369,600 November 1 AstraZeneca/Oxford 3.0 million 904,620 Mexico 2.2 million May 27 AstraZeneca/Oxford 129 million 3.3 million Nicaragua 134,400 November 13 AstraZeneca/Oxford 6.6 million 2.4 million Panama 74,400 September 15 AstraZeneca/Oxford 4.3 million 148,800 Paraguay 39,600 September 30 Sinopharm 7.1 million 1.2 million Peru 1.2 million November 10 Sinopharm 33 million 3.6 million Saint Kitts and 21,600 April 7 AstraZeneca/Oxford 53,000 21,600 Nevis Saint Lucia 24,000 September 1 AstraZeneca/Oxford 184,000 74,400 Saint Vincent 21,600 May 25 AstraZeneca/Oxford 111,000 45,600 and the Grenadines Suriname 26,400 August 9 AstraZeneca/Oxford 587,000 79,200 Trinidad and 33,600 August 11 AstraZeneca/Oxford 1.4 million 101,200 Tobago Uruguay 50,400 September 1 AstraZeneca/Oxford 3.5 million 148,800 Venezuela 2.6 million November 13 Sinopharm 28 million 5.9 million Sources: WHO, UNICEF, GAVI, releases from local authorities (Reporting by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki and Antonis Triantafyllou in Gdansk; Editing by David Evans and Emelia Sithole-Matarise)

Our Standards: The Thomson Reuters Trust Principles.